![](/img/cover-not-exists.png)
Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4–6 years after a first dose: results from a phase 2 trial
Leroux-Roels, Geert, Bebia, Zourab, Maes, Cathy, Aerssens, Annelies, De Boever, Fien, Grassano, Luca, Buffi, Giada, Margarit, Immaculada, Karsten, Annette, Cho, Stephen, Slobod, Karen, Corsaro, Bart,Language:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciz737
Date:
August, 2019
File:
PDF, 1.48 MB
english, 2019